Published in Blood Weekly, December 21st, 2000
They suggest infusing adult chemotherapy patients with greater numbers of cord blood cells may result in quicker neutrophil engraftment.
I. McNiece and colleagues associated with UC's Bone Marrow Transplantation Program noted that because a single unit of cord blood has relatively few cells, allogeneic cord blood (CB) products have been used to boost cellular support primarily in small children undergoing high-dose chemotherapy.
Additionally, they said, a median of 26 days was necessary for neutrophil engraftment to occur...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2000-12-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.